SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

被引：0
|
作者：
Michael E. Wechsler
Gene Colice
Janet M. Griffiths
Gun Almqvist
Tor Skärby
Teresa Piechowiak
Primal Kaur
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
机构：
[1] National Jewish Health,Respiratory & Immunology
[2] BioPharmaceuticals R&D,Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology
[3] AstraZeneca,Late Respiratory & Immunology
[4] BioPharmaceuticals R&D,Development Operations
[5] AstraZeneca,Biometrics, Late Respiratory & Immunology
[6] BioPharmaceuticals R&D,Biometrics, Late Respiratory & Immunology
[7] AstraZeneca,Global Medical Respiratory
[8] BioPharmaceuticals R&D,undefined
[9] AstraZeneca,undefined
[10] Amgen,undefined
[11] BioPharmaceuticals R&D,undefined
[12] BioPharmaceuticals R&D,undefined
[13] BioPharmaceuticals R&D,undefined
[14] AstraZeneca,undefined
来源：
Respiratory Research | / 21卷
关键词：
Alarmin; Asthma; Asthma control; Exacerbation; Epithelial; Oral corticosteroids; SOURCE; Steroid-sparing; Tezepelumab; TSLP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
    Wechsler, Michael E.
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Skarby, Tor
    Piechowiak, Teresa
    Kaur, Primal
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [2] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [3] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    Respiratory Research, 21
  • [4] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Ponnarambil, Sandhia
    Downie, John
    Bowen, Karin
    Hellqvist, Asa
    Colice, Gene
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [5] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Sandhia Ponnarambil
    John Downie
    Karin Bowen
    Åsa Hellqvist
    Gene Colice
    Respiratory Research, 21
  • [6] CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
    Emson, Claire
    Diver, Sarah
    Chachi, Latifa
    Megally, Ayman
    Small, Cherrie
    Downie, John
    Parnes, Jane R.
    Bowen, Karin
    Colice, Gene
    Brightling, Chris E.
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [7] CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
    Claire Emson
    Sarah Diver
    Latifa Chachi
    Ayman Megally
    Cherrie Small
    John Downie
    Jane R. Parnes
    Karin Bowen
    Gene Colice
    Chris E. Brightling
    Respiratory Research, 21
  • [8] A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma
    Kishiyama, JL
    Valacer, D
    Cunningham-Rundles, C
    Sperber, K
    Richmond, GW
    Abramson, S
    Glovsky, M
    Stiehm, R
    Stocks, J
    Rosenberg, L
    Shames, RS
    Corn, B
    Shearer, WT
    Bacot, B
    DiMaio, M
    Tonetta, S
    Adelman, DC
    CLINICAL IMMUNOLOGY, 1999, 91 (02) : 126 - 133
  • [9] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    William W. Busse
    Jorge F. Maspero
    Klaus F. Rabe
    Alberto Papi
    Sally E. Wenzel
    Linda B. Ford
    Ian D. Pavord
    Bingzhi Zhang
    Heribert Staudinger
    Gianluca Pirozzi
    Nikhil Amin
    Bolanle Akinlade
    Laurent Eckert
    Jingdong Chao
    Neil M. H. Graham
    Ariel Teper
    Advances in Therapy, 2018, 35 : 737 - 748
  • [10] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Busse, William W.
    Maspero, Jorge F.
    Rabe, Klaus F.
    Papi, Alberto
    Wenzel, Sally E.
    Ford, Linda B.
    Pavord, Ian D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Pirozzi, Gianluca
    Amin, Nikhil
    Akinlade, Bolanle
    Eckert, Laurent
    Chao, Jingdong
    Graham, Neil M. H.
    Teper, Ariel
    ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
12345